CClinicalTrials.gg
CompletedNCT06648408Updated May 18, 2026

Ballet Training in Children With Idiopathic Coxa Antetorta

An interventional study of Balett Training in Femoral Anteversion, sponsored by University Children's Hospital Basel. Completed at 1 site in Switzerland. Open to participants aged 8 Years to 12 Years. Per ClinicalTrials.gov, last updated 2026-05-18.

Sponsored by University Children's Hospital Basel · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
5
Allocation
Randomized
Ages
8 Years to 12 Years
Sex
All
01

Study summary

This study looks at how ballet training affects movement and personal feelings in children with a condition called idiopathic coxa antetorta.

Read the detailed description

Increased femoral anteversion (IFA) occurs when the top of the thigh bone tilts forward more than normal. Many healthy kids and teens aren't considered to have a problem with this as long as they show no symptoms, since it often corrects itself by the time they reach ages 12 to 14. However, experts believe this condition might lead to complications later in life. Research indicates that children with IFA may be more prone to issues like kneecap misalignment, knee pain, and even arthritis as they grow older. This is likely due to the way their knees bend differently when they walk. Kids with IFA often walk with their toes pointing inward, which increases their chances of tripping and falling. They may also experience pain that interferes with their daily activities. It is assumed that strengthening the hips and improving hip flexibility could help reduce the need for compensatory movements, ultimately lowering the risk of tripping, falling, and experiencing pain in everyday life. This study is a randomized controlled trial aimed at examining how ballet training influences knee movement-specifically knee flexion-during walking in children with idiopathic coxa antetorta. The goal is to determine whether ballet training enhances the children's overall mobility and how they feel about their ability to move. Additionally, the study seeks to find out how this training can be effectively incorporated into the daily routines of affected schoolchildren.

02

Conditions studied

  • Femoral Anteversion

Keywords

  • Increased femoral anteversion (IFA)
  • Idiopathic coxa antetorta
  • Childhood knee pain
  • Physical activity intervention
  • Ballet training for children
  • Hip strength and mobility
  • Knee flexion in children
  • Exercise for hip flexibility
  • In-toeing gait in children
03

In context

Lead sponsor

University Children's Hospital Basel is the lead sponsor of 27 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Diagnosis of idiopathic coxa antetorta with FNA> 30°
  • Children between 8 and 12 years of age
  • Cognitive abilities must include: Ability to actively participate in a 60-minute ballet class; Ability to communicate pain or discomfort; Ability to attend training, testing and follow-up sessions. All included participants can make decisions on their own and do not show any signs of mental or cognitive limitations.

Exclusion criteria

Exclusion Criteria:

  • Any surgery within 6 months prior to the start of the study or surgery scheduled during the study period. Other medications can be continued as prescribed by the participants' physician
  • Known cardiovascular or pulmonary diseases that have not received medical clearance to participate in the physical exercise intervention
  • Neurological or other musculoskeletal comorbidities
  • The children should not have completed any ballet training in the last 12 months
  • Pregnancy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
5 participants (actual)

Study arms

  • Experimental
    Ballet training

    The children in this arm of the study will receive ballet training.

    Procedure: Balett Training

  • No intervention
    Control group

    The children in the control group in this study will not receive any intervention, according to the German guidelines for idiopathic coxa antetorta 2002. This is in line with the standard approach, as children in this developmental phase typically do not receive therapy for this condition.

Interventions

  • ProcedureBalett Training

    The ballet training will happen twice a week for six weeks, with each session lasting 60 minutes, for a total of 12 sessions. These sessions will be held in groups of 10 to 12 children and led by experienced ballet teachers. The classes will follow a beginner-level ballet routine, introducing the kids to ballet techniques in a fun and playful way, making sure they learn the movements step by step. Each lesson will follow the same structure, allowing the children to improve their skills week after week. In addition to the group sessions, the children will be given a 10-minute daily home exercise program. This will include simple ballet exercises they learned in their first class, which they should practice on the five days when they don't have ballet sessions. The children will track their practice in a child-friendly diary designed just for them.

06

What researchers measure

Primary outcomes

  1. Kinematic measurement and

    This study will track knee flexion during the mid-stance phase of walking, as children with coxa antetorta often show increased knee bending, which can lead to future knee issues. The children's walking will be recorded using a 2D gait analysis system on the C-Mill treadmill, offering accurate results while minimizing stress and reducing the chance of errors.

    Time frame: Week1 and week 8

  2. Subjective functional mobility

    The children's mobility and quality of life will be assessed, using the parent-reported Pediatric Outcomes Data Collection Instrument (PODCI), a reliable questionnaire designed for children with musculoskeletal conditions. It measures various aspects of daily functioning and well-being, and the scores range from 0 to 100, with lower scores indicating more difficulties.

    Time frame: Week1 and week 8

Secondary outcomes

  1. Gait Analysis

    Gait analysis will be performed on the C-Mill by Motek treadmill. To ensure safety while determining the speed at which a stumble might occur, the children will be secured with a harness to prevent falls or injuries.

    Time frame: Week1 and week 8

  2. Measurement of femoral anteversion angle (°)

    The femoral neck anteversion (FNA) will be measured using Craig's test, where we assess the angle at the prominent part of the hip while the child lies face down with their knee bent.

    Time frame: Week1 and week 8

  3. Measurement of hip strength (N)

    The maximum strength of the hip flexors, extensors, external rotators, and abductors will be measured using dynamometers, which are reliable tools for checking how strong these muscles are.

    Time frame: Week1 and week 8

  4. Measurement of hip mobility (°)

    The passive range of motion for internal and external rotation will be measured using a goniometer while the participants lie face down with their hip straight and knee bent at a 90° angle.

    Time frame: Week1 and week 8

  5. Feasibility assessment

    To evaluate how feasible the intervention is, the number of training sessions the children actually attend will be tracked and compared to the planned sessions and calculate the attendance rate. The ballet teacher will maintain an attendance list, and the children will also record their participation in a specially designed, child-friendly diary.

    Time frame: Week 8

07

Study locations

1 site
  • Universitäts-Kinderspital beider Basel (UKBB)
    Basel, 4031, Switzerland
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06648408
Lead sponsor
University Children's Hospital Basel
Responsible party
Sponsor
First posted
Oct 18, 2024
Start date
Aug 8, 2024
Primary completion
Apr 30, 2025
Completion
Apr 30, 2025
Last update
May 18, 2026

Study contacts

Michèle Widmer, Dr. med.
principal investigator · Universitäts-Kinderspital beider Basel (UKBB)

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion